Global Myeloproliferative Disorders Drugs Market size was estimated at USD 6.49 billion in 2023. During the forecast period between 2024 and 2029, the size of Global Myeloproliferative Disorders Drugs Market is projected to grow at a CAGR of 4.78% reaching a value of USD 7.58 billion by 2030. The Global Myeloproliferative Disorders Drugs Market is poised for substantial growth, driven by the proliferation of novel drugs and a robust pipeline.